Abstract is out today. I'm not expecting much (in it), but when the data is presented I will be looking to see if there is activity in those with liver metastases and as a single agent. Also, if paclitaxel adds anything, does an antibody help, and does the triple combination outperform.
Market Data 
Markets 
AI
